Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 46, 2010, Pages 19903-19908

  Arwert, Esther N ^a   Lal, Rohit ^b   Quist, Sven ^a   Rosewell, Ian ^c   Van Rooijen, Nico ^d   Watt, Fiona M ^a  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Differentiation

Indexed keywords

CLODRONIC ACID; CYCLOSPORIN A; DEXAMETHASONE; INTERLEUKIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER INCIDENCE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CELL STIMULATION; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; EPIDERMIS CELL; FEMALE; GAMMA DELTA T LYMPHOCYTE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; KERATOACANTHOMA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; SKIN INJURY; SKIN PAPILLOMA; TRANSGENICS; TUMOR VOLUME;

MAMMALIA; MUS; MUS MUSCULUS;

EID: 78650573907     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1007404107     Document Type: Article

References (39)

1. Janes SM, Watt FM (2006) New roles for integrins in squamous-cell carcinoma. Nat Rev Cancer 6:175-183.
2. Watt FM (2002) Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21:3919-3926.
3. Yang X, Pursell B, Lu S, Chang TK, Mercurio AM (2009) Regulation of β4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition. J Cell Sci 122:2473-2480.
4. Haase I, Hobbs RM, Romero MR, Broad S, Watt FM (2001) A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis. J Clin Invest 108:527-536.
5. Hobbs RM, Silva-Vargas V, Groves R, Watt FM (2004) Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions. J Invest Dermatol 123:503-515.
6. Scholl FA, et al. (2007) Mek1/2 MAPK kinases are essential for mammalian development, homeostasis, and Raf-induced hyperplasia. Dev Cell 12:615-629.
7. Sieweke MH, Stoker AW, Bissell MJ (1989) Evaluation of the cocarcinogenic effect of wounding in Rous sarcoma virus tumorigenesis. Cancer Res 49:6419-6424.
8. Egeblad M, Nakasone ES, Werb Z (2010) Tumors as organs: Complex tissues that interface with the entire organism. Dev Cell 18:884-901.
9. Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211-217.
10. Sanders S, Busam KJ, Halpern AC, Nehal KS (2002) Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: Case report and review of a controversial therapy. Dermatol Surg 28:954-958.
11. Brown K, Buchmann A, Balmain A (1990) Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc Natl Acad Sci USA 87:538-542.
12. Kramata P, et al. (2005) Patches of mutant p53-immunoreactive epidermal cells induced by chronic UVB irradiation harbor the same p53 mutations as squamous cell carcinomas in the skin of hairless SKH-1 mice. Cancer Res 65:3577-3585.
13. Gurtner GC, Werner S, Barrandon Y, Longaker MT (2008) Wound repair and regeneration. Nature 453:314-321.
14. Stosić-Grujicić S, Lukić ML (1992) Glucocorticoid-induced keratinocyte-derived interleukin-1 receptor antagonist(s). Immunology 75:293-298.
15. Marionnet AV, Chardonnet Y, Viac J, Schmitt D (1997) Differences in responses of interleukin-1 and tumor necrosis factor α production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures. Exp Dermatol 6:22-28.
16. Lim WK, et al. (2005) Suppression of immune-mediated ocular inflammation in mice by interleukin 1 receptor antagonist administration. Arch Ophthalmol 123:957-963.
17. Ikuta K, et al. (1990) A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell 62:863-874.
18. Stratis A, et al. (2006) Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 116:2094-2104.
19. Robertson FM, et al. (1995) Interleukin-1a gene expression during wound healing. Wound Repair Regen 3:473-484.
20. Lee RT, et al. (1997) Mechanical deformation promotes secretion of IL-1 α and IL-1 receptor antagonist. J Immunol 159:5084-5088.
21. Bianchi ME (2007) DAMPs, PAMPs and alarmins: All we need to know about danger. J Leukoc Biol 81:1-5.
22. Murphy JE, Morales RE, Scott J, Kupper TS (2003) IL-1 α, innate immunity, and skin carcinogenesis: The effect of constitutive expression of IL-1 a in epidermis on chemical carcinogenesis. J Immunol 170:5697-5703.
23. Dinarello CA (2010) Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev 29:317-329.
24. Skeen MJ, Rix EP, Freeman MM, Ziegler HK (2001) Exaggerated proinflammatory and Th1 responses in the absence of γ/δ T cells after infection with Listeria monocytogenes. Infect Immun 69:7213-7223.
25. Seo N, Egawa K (1995) Suppression of cytotoxic T lymphocyte activity by γ/δ T cells in tumor-bearing mice. Cancer Immunol Immunother 40:358-366.
26. Xu Y, Kapp JA (2002) Gammadelta T cells in anterior chamber-induced tolerance in CD8(+) CTL responses. Invest Ophthalmol Vis Sci 43:3473-3479.
27. Schwacha MG (2009) Gammadelta T-cells: Potential regulators of the post-burn inflammatory response. Burns 35:318-326.
28. Strid J, Tigelaar RE, Hayday AC (2009) Skin immune surveillance by T cells - A new order? Semin Immunol 21:110-120.
29. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436-444.
30. Girardi M, et al. (2003) The distinct contributions of murine T cell receptor (TCR) gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer. J Exp Med 198:747-755.
31. Zucali JR, et al. (1986) Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2. J Clin Invest 77:1857-1863.
32. Allavena P, Sica A, Garlanda C, Mantovani A (2008) The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222:155-161.
33. Hagemann T, et al. (2008) "Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med 205:1261-1268.
34. Allavena P, Sica A, Solinas G, Porta C, Mantovani A (2008) The inflammatory microenvironment in tumor progression: The role of tumor-associated macrophages. Crit Rev Oncol Hematol 66:1-9.
35. Gupta PB, Chaffer CL, Weinberg RA (2009) Cancer stem cells: Mirage or reality? Nat Med 15:1010-1012.
36. Nagy AaRJ (2000) Gene Targeting: A Practical Approach (Oxford University Press, New York).
37. Cui YZ, et al. (2002) Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant 30:843-849.
38. Jeffery R, Poulsom R, Alison MR (2009) Sources of adult hepatic stem cells: Haematopoietic. Methods Mol Biol 481:141-154.
39. Niemann C, Owens DM, Schettina P, Watt FM (2007) Dual role of inactivating Lef1 mutations in epidermis: Tumor promotion and specification of tumor type. Cancer Res 67:2916-2921.